EMR CEO now directly owns 327,915 shares after award activity
Rhea-AI Filing Summary
Emerson Electric (EMR) reported insider transactions by President & CEO Surendralal Karsanbhai on 11/03/2025. He acquired 163,588 shares upon payout of earned units under a performance share award pursuant to a shareholder‑approved plan. The company withheld 72,061 shares for required taxes at a fair market value of $139.46 per share. He also received a grant of 54,475 restricted stock units under a shareholder‑approved plan.
After the reported transactions, he directly owned 327,915 shares of common stock. Additional indirect holdings include positions in benefit plans and a trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 146,002 shares
Net Buy
9 txns
Insider
Karsanbhai Surendralal Lanca
Role
President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 163,588 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 72,061 | $139.46 | $10.05M |
| Grant/Award | Common Stock | 54,475 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 327,915 shares (Direct);
Common Stock — 453.26 shares (Indirect, Custodian Account for Daughter);
Common Stock — 453.26 shares (Indirect, Custodian Account for Son);
Common Stock — 164,957.0331 shares (Indirect, By Trust);
Common Stock — 49.434 shares (Indirect, 401(k) excess plan);
Common Stock — 2,485.557 shares (Indirect, 401(k) excess plan II);
Common Stock — 660.54 shares (Indirect, 401(k) plan)
Footnotes (6)
- F1. Acquisition of shares pursuant to Rile 16b-3 upon payout of 163,588 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2025.
- F2. Price is not applicable to the acquisition described in Note 1.
- F3. Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1.
- F4. Fair market value on date of withholding described in Note 1.
- F5. Grant to Reporting Person of 54,475 restricted stock units under shareholder approved benefit plan pursuance to Rule 16b-3(d).
- F6. Price is not applicable to acquisitions resulting from grants of restricted stock units.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did EMR CEO report on Form 4?
He reported the payout of 163,588 earned units into common shares, tax withholding of 72,061 shares at $139.46, and a grant of 54,475 RSUs.
What is the date of the reported transactions for EMR (EMR)?
The earliest transaction date disclosed is 11/03/2025.
What additional equity was granted to the CEO?
A grant of 54,475 restricted stock units was reported under a shareholder‑approved plan.